Reckitt Benckiser to Stop Selling Suboxone Tablets

Reckitt Benckiser Group Plc (RB/) will cease production of the Suboxone opioid-dependency drug in tablet form, a person familiar with the decision said today.

The person, who declined to be named, said an announcement from the company will be made later today.

To contact the reporter on this story: Matthew Boyle in London at mboyle20@bloomberg.net

To contact the editor responsible for this story: Sara Marley at smarley1@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.